AperçuGraphiqueActualitésTraderScreen

BVT Call 115 MRK 21.03.2025/  DE000VC06F75  /

EUWAX
12/11/2024  08:43:29 Chg.-0.032 Bid22:00:38 Demandez à22:00:38 Sous-jacent Prix d'exercice Date d'expiration Type d'option
0.142EUR -18.39% -
Bid taille: -		 -
Ask la taille: -		 Merck and Co Inc 115.00 USD 21/03/2025 Call
TeleTrader 31/10 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 31/07 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 30/07 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 17/07 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
TeleTrader 01/07 US closes higher after data
GlobeNewswire 27/06 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 26/06 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 30/05 Monte Rosa Therapeutics Announces Leadership Team Promotions
TeleTrader 28/05 US markets turn to losses, Dow plunges 330 points
GlobeNewswire 28/05 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 23/05 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 23/05 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 16/05 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 14/05 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 08/05 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 25/04 American Kidney Fund Launches National Kidney Health Equity Media Campaign
TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 24/04 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire 18/04 The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 15/04 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 09/04 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire 05/04 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 03/04 TOMI Environmental Solutions Receives Gold Safety Award from Highwire